Optimizing MPN Patient Outcomes: The Holistic Approach
by David Wallace
Join us as we sit down with renowned MPN expert, Dr. Angela Fleischman, for an enlightening conversation about living optimally with Myeloproliferative Neoplasms. Dive deep into actionable strategies for managing myelofibrosis and discover tips to enhance your journey with MPNs.
Your host, David Wallace, founder of PV Reporter and MPN Cancer Connection, takes on the dual role of interviewer and patient advocate, ensuring you get the most from this insightful session.
- Just a short time after our interview, Momelotonib (Ojjaara) was FDA approved for the treatment of myelofibrosis with anemia.
🌟 Don’t miss out! This is the second installment in our acclaimed “Patients Are Asking” series. Tune in to stay informed and empowered.
